Vivian E von Gruenigen

Summary

Affiliation: Case Western Reserve University
Country: USA

Publications

  1. ncbi Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, OH 44106, USA
    Gynecol Oncol 103:120-6. 2006
  2. ncbi A case of chronic paclitaxel administration in ovarian cancer
    Vivian E von Gruenigen
    Division of Gynecologic Oncology, University MacDonald Women s Hospital University Hospitals of Cleveland and the Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA
    Gynecol Oncol 89:532-5. 2003
  3. ncbi Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, MacDonald Women s Hospital, and the Ireland Cancer Center, Cleveland, Ohio 44106, USA
    Cancer 107:2786-91. 2006
  4. ncbi The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Summa Health System, 525 E Market Street, Akron, OH 44309, USA
    Anticancer Res 23:3279-87. 2003
  5. ncbi Clinical disease course during the last year in ovarian cancer
    Vivian E von Gruenigen
    University Hospitals of Cleveland MacDonald Women s Hospital, Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44016, USA
    Gynecol Oncol 90:619-24. 2003
  6. ncbi Futility: clinical decisions at the end-of-life in women with ovarian cancer
    Vivian E von Gruenigen
    Department of Reproductive Biology, Division of Gynecologic Oncology, University MacDonald Women s Hospital, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Gynecol Oncol 97:638-44. 2005
  7. ncbi The impact of obesity and age on quality of life in gynecologic surgery
    Vivian E von Gruenigen
    University Hospitals of Cleveland, MacDonald Womens Hospital, The Ireland Cancer Center, Cleveland, OH, USA
    Am J Obstet Gynecol 193:1369-75. 2005
  8. pmc Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy
    Vivian E von Gruenigen
    University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
    Health Qual Life Outcomes 4:84. 2006
  9. pmc Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials
    Vivian E von Gruenigen
    Department of Reproductive Biology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Cancer 115:4857-64. 2009
  10. pmc The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study
    Vivian E von Gruenigen
    Summa Health System, 525 East Market Med II, POB 2090, Akron, OH 44309, USA
    Gynecol Oncol 124:379-82. 2012

Collaborators

Detail Information

Publications35

  1. ncbi Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, OH 44106, USA
    Gynecol Oncol 103:120-6. 2006
    ..To prospectively evaluate quality of life (QoL), use of complementary and alternative medicine (CAM), and diet/exercise changes in ovarian cancer patients during the first 6 months following diagnosis...
  2. ncbi A case of chronic paclitaxel administration in ovarian cancer
    Vivian E von Gruenigen
    Division of Gynecologic Oncology, University MacDonald Women s Hospital University Hospitals of Cleveland and the Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA
    Gynecol Oncol 89:532-5. 2003
    ..When ovarian cancer recurs, chemotherapy is continued when patients respond to therapy. However, the disease may become stable. Stable disease is clinically relevant and no longer an indication of treatment failure...
  3. ncbi Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, MacDonald Women s Hospital, and the Ireland Cancer Center, Cleveland, Ohio 44106, USA
    Cancer 107:2786-91. 2006
    ..The objective was to examine whether rates of disease recurrence, treatment-related adverse effects, and survival differed between obese or morbidly obese and nonobese patients...
  4. ncbi The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Summa Health System, 525 E Market Street, Akron, OH 44309, USA
    Anticancer Res 23:3279-87. 2003
    ..The objective was to evaluate the cytotoxic effect and mechanism of action of vitamins C (VC) and K3 (VK3) on ovarian carcinoma...
  5. ncbi Clinical disease course during the last year in ovarian cancer
    Vivian E von Gruenigen
    University Hospitals of Cleveland MacDonald Women s Hospital, Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44016, USA
    Gynecol Oncol 90:619-24. 2003
    ..The objective was to determine whether there were changes in the pattern and nature of hospitalizations during the last year that could be used in the assessment of whether chemotherapy should be continued...
  6. ncbi Futility: clinical decisions at the end-of-life in women with ovarian cancer
    Vivian E von Gruenigen
    Department of Reproductive Biology, Division of Gynecologic Oncology, University MacDonald Women s Hospital, 11100 Euclid Avenue, Cleveland, OH 44106, USA
    Gynecol Oncol 97:638-44. 2005
    ....
  7. ncbi The impact of obesity and age on quality of life in gynecologic surgery
    Vivian E von Gruenigen
    University Hospitals of Cleveland, MacDonald Womens Hospital, The Ireland Cancer Center, Cleveland, OH, USA
    Am J Obstet Gynecol 193:1369-75. 2005
    ..This study was undertaken to prospectively evaluate the effect of early stage endometrial cancer, age, and obesity on quality of life (QOL)...
  8. pmc Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy
    Vivian E von Gruenigen
    University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
    Health Qual Life Outcomes 4:84. 2006
    ..The objective was to assess the association between patient's satisfaction with care and symptom severity and to evaluate test-retest of a satisfaction survey in this study population...
  9. pmc Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials
    Vivian E von Gruenigen
    Department of Reproductive Biology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA
    Cancer 115:4857-64. 2009
    ..The objective of this study was to assess which quality-of-life (QOL) line items on the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) were associated with low QOL in women who were receiving chemotherapy for ovarian cancer...
  10. pmc The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study
    Vivian E von Gruenigen
    Summa Health System, 525 East Market Med II, POB 2090, Akron, OH 44309, USA
    Gynecol Oncol 124:379-82. 2012
    ..To explore the association between baseline quality of life (QOL) scores and overall survival (OS) in ovarian cancer patients receiving adjuvant chemotherapy...
  11. doi Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy
    Vivian E von Gruenigen
    Summa Health System Akron City Hospital, Akron, OH 44309, USA
    Gynecol Oncol 122:328-33. 2011
    ..This study aimed to assess the feasibility of a lifestyle intervention for promoting physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer...
  12. ncbi Lifestyle challenges in endometrial cancer survivorship
    Vivian E von Gruenigen
    Summa Health System Akron City Hospital, Akron, Ohio 44309, USA
    Obstet Gynecol 117:93-100. 2011
    ..To examine lifestyle behaviors that may contribute to endometrial cancer survivor morbidity and to identify associations with quality of life...
  13. pmc A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change
    Vivian E von Gruenigen
    University Hospitals Case Medical Center, Cleveland, OH, USA
    Health Qual Life Outcomes 7:17. 2009
    ..To examine the effects of a 6 month lifestyle intervention on quality of life, depression, self-efficacy and eating behavior changes in overweight and obese endometrial cancer survivors...
  14. pmc A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study
    Vivian E von Gruenigen
    Department of Reproductive Biology, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
    J Pain Symptom Manage 39:839-46. 2010
    ..Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions...
  15. pmc Effect of method of administration on longitudinal assessment of quality of life in gynecologic cancer: an exploratory study
    Karen M Gil
    Department of Obstetrics and Gynecology, Akron General Medical Center, Akron, Ohio, USA
    Health Qual Life Outcomes 3:6. 2005
    ..This study examined whether changes measured using a computer version of the Functional Assessment of Cancer Therapy - General (FACT-G) on two occasions would be obtained if patients completed a paper version on one of the two occasions...
  16. pmc Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgery
    Karen M Gil
    Department of Obstetrics and Gynecology, Akron General Medical Center, Akron, Ohio 44302, USA
    Health Qual Life Outcomes 5:25. 2007
    ....
  17. doi Palliative and end-of-life care for patients with ovarian cancer
    Steven M Radwany
    Summa Health System, Palliative Care and Hospice Services, Akron, Ohio, USA
    Clin Obstet Gynecol 55:173-84. 2012
    ..End-of-life care focuses on comfort, control, meaning, and support that become particularly intense when death is imminent...
  18. doi Physical activity and gynecologic cancer survivorship
    Karen M Gil
    Akron General Medical Center, Akron, OH, USA
    Recent Results Cancer Res 186:305-15. 2011
    ..The effects of increased PA on recurrence or survival in gynecological cancers are not yet established, and randomized controlled trials are needed for definitive data...
  19. doi Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study
    Vivian E von Gruenigen
    Department of Obstetrics and Gynecology, Summa Akron City Hospital, Akron, Ohio 44309, USA
    Anticancer Drugs 23:724-30. 2012
    ..6, 41.3) had stable disease. An oral topotecan dose of 14 mg/week for 3 consecutive weeks out of 4 is mostly associated with acceptable toxicities and may be considered for use in future single-agent phase II trials...
  20. ncbi Microscopic aspects of autoschizic cell death in human ovarian carcinoma (2774) cells following vitamin C, vitamin K3 or vitamin C:K3 treatment
    Jacques Gilloteaux
    Department of Urology, Summa Health System, Akron, OH 44304, USA
    Microsc Microanal 9:311-29. 2003
    ..These results also suggest that the vitamin combination may find clinical use in the treatment of ovarian cancer...
  21. doi A review of issues surrounding quality of life among women with ovarian cancer
    Lucybeth Nieves Arriba
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH, USA
    Gynecol Oncol 119:390-6. 2010
    ..This trend has placed increasing attention upon the quality of life (QoL). The aim of this study was to review the existing literature on QoL, including measurement tools, and to explore opportunities to optimize well-being...
  22. doi Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship
    Amanda Nickles Fader
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
    Gynecol Oncol 114:121-7. 2009
    ....
  23. ncbi Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer
    Denise Uyar
    Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Medical College of Wisconsin, WI, USA
    Gynecol Oncol 98:403-8. 2005
    ..Elderly patients are less likely to receive surgery and platinum-based combination chemotherapy than younger patients. We evaluated multi-institutional management of ovarian cancer in the elderly...
  24. ncbi Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapy
    Karen M Gil
    Department of Obstetrics and Gynecology, Akron General Medical Center, 224 West Exchange Street, Akron, OH 44302, USA
    Gynecol Oncol 103:247-52. 2006
    ..To prospectively examine body weight changes in women with newly diagnosed ovarian cancer receiving surgery and adjuvant chemotherapy. Body composition was examined in a subset of these women...
  25. doi Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial
    Vivian E von Gruenigen
    University Hospitals Case Medical Center, Division of Gynecologic Oncology, 11100 Euclid Avenue, Room 7128, Cleveland, Ohio 44106, USA
    Gynecol Oncol 109:19-26. 2008
    ..The purpose of this study was to assess feasibility of a lifestyle intervention program for promoting weight loss, change in eating behaviors, and increased physical activity in obese ECS...
  26. doi A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study
    Joan L Walker
    Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City, OK 73190, USA
    Gynecol Oncol 112:78-84. 2009
    ..To determine the maximum tolerated dose (MTD) of weekly paclitaxel and cisplatin chemotherapy concurrent with extended field irradiation in women with cervical cancer metastatic to the para-aortic nodes...
  27. doi Management of the late effects of treatments for gynecological cancer
    Stephen Andrews
    Gynecologic Oncology, Summa Health System, Akron, OH, USA
    Curr Opin Oncol 25:566-70. 2013
    ..Several treatment modalities are used to treat gynecologic malignancies, including surgery, radiotherapy, and chemotherapy. Each modality can be responsible for causing late-term side-effects...
  28. doi The effect of sleep disturbance on quality of life in women with ovarian cancer
    Samith Sandadi
    Department of Obstetrics and Gynecology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
    Gynecol Oncol 123:351-5. 2011
    ..To estimate the prevalence of sleep disturbances, and to determine if there is an association between sleep disturbances with quality of life (QOL), depression or clinical demographic variables...
  29. ncbi Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial
    Vivian E von Gruenigen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospital Case Medical Center, Case School of Medicine, Cleveland, Ohio, USA
    Obstet Gynecol 109:942-7. 2007
    ..To compare pain, adverse effects and recurrence of dysplasia in patients with vaginal intraepithelial neoplasia or vulvar intraepithelial neoplasia prospectively treated by carbon dioxide laser or ultrasonic surgical aspiration...
  30. pmc Robotic-assisted hysterectomy for the management of severe endometriosis: a retrospective review of short-term surgical outcomes
    Mohamed A Bedaiwy
    Department of Obstetrics and Gynecology, Case Western Reserve University, Cleveland, OH, USA
    JSLS 17:95-9. 2013
    ..The secondary objective was to explore whether the stage of endometriosis affected surgical outcome...
  31. pmc Quality of life in endometrial cancer survivors: what does obesity have to do with it?
    Amanda Nickles Fader
    Division of Gynecologic Oncology, Greater Baltimore Medical Center Johns Hopkins Hospital, Baltimore, MD 21204, USA
    Obstet Gynecol Int 2011:308609. 2011
    ..This paper highlights the importance of incorporating health-related QOL assessments and obesity interventions during the survivorship period...
  32. ncbi Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
    Anita Schwandt
    Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Invest New Drugs 32:729-38. 2014
    ..Sorafenib in combination with carboplatin and paclitaxel improved RR and PFS; however, there were increased grade and frequencies of toxicities. ..
  33. doi Rates of self-reported antenatal mood symptoms and obstetric management practices
    Michele L McCarroll
    Summa Health System, Akron, OH
    Obstet Gynecol 123:155S-6S. 2014
    ..The objective of this study was to determine the prevalence of antenatal mood symptoms, implementation of a treatment plan, and associations with race and payor status...
  34. ncbi Does enhanced "bundling" criteria improve outcomes? A comparative study of elective inductions
    Tiffany H Kenny
    Department of Obstetrics and Gynecology, Summa Akron City Hospital, 525 East Market, Medical II, P O Box 2090, Akron, OH 44309, USA
    J Reprod Med 58:402-10. 2013
    ..To assess outcomes and costs of dyads achieving elective induction bundle criteria with a favorable Bishop score...
  35. doi The financial performance of labor and delivery units
    Vivian E von Gruenigen
    Summa Akron City Hospital, Department of Obstetrics and Gynecology, Summa Health System Akron, OH
    Am J Obstet Gynecol 209:17-9. 2013
    ....